{"id":"cholinesterase-inhibitor","safety":{"commonSideEffects":[{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Vomiting"},{"rate":null,"effect":"Diarrhea"},{"rate":null,"effect":"Muscle cramps"},{"rate":null,"effect":"Bradycardia"},{"rate":null,"effect":"Syncope"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"These drugs inhibit acetylcholinesterase, the enzyme responsible for degrading acetylcholine at the neuromuscular junction and in the central nervous system. By preventing acetylcholine breakdown, the drugs increase acetylcholine concentration and duration of action at cholinergic receptors, enhancing neuromuscular and cognitive function. This mechanism is particularly useful in conditions characterized by cholinergic deficiency, such as Alzheimer's disease and myasthenia gravis.","oneSentence":"Cholinesterase inhibitors block the enzyme that breaks down acetylcholine, allowing acetylcholine to accumulate in the synapse and enhance cholinergic neurotransmission.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:05:46.102Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Alzheimer's disease (cognitive decline)"},{"name":"Myasthenia gravis"}]},"trialDetails":[{"nctId":"NCT01747213","phase":"PHASE1","title":"Bisnorcymserine in Healthy Adult Volunteers","status":"COMPLETED","sponsor":"National Institute on Aging (NIA)","startDate":"2013-01-29","conditions":"Healthy Volunteers","enrollment":75},{"nctId":"NCT06903910","phase":"PHASE2","title":"Investigating the Cholinergic Contribution to Gait Dysfunction in Parkinson's Disease","status":"COMPLETED","sponsor":"University of Virginia","startDate":"2024-11-01","conditions":"Parkinson Disease","enrollment":6},{"nctId":"NCT07208344","phase":"EARLY_PHASE1","title":"Intravenous Infusion of Umbilical Cord Blood as an Adjunctive Treatment for Alzheimer's Disease","status":"RECRUITING","sponsor":"Anhui Provincial Hospital","startDate":"2025-07-31","conditions":"Alzheimer Disease (AD)","enrollment":30},{"nctId":"NCT05564169","phase":"PHASE3","title":"Masitinib in Patients With Mild Alzheimer's Disease","status":"NOT_YET_RECRUITING","sponsor":"AB Science","startDate":"2026-06","conditions":"Alzheimer Disease","enrollment":600},{"nctId":"NCT05438264","phase":"EARLY_PHASE1","title":"Effect of Donepezil on Speech Recognition in Cochlear Implant Users","status":"ACTIVE_NOT_RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2023-03-10","conditions":"Bilateral Sensorineural Hearing Loss","enrollment":50},{"nctId":"NCT04226248","phase":"PHASE3","title":"CHIEF-PD (CHolinesterase Inhibitor to prEvent Falls in Parkinson's Disease)","status":"COMPLETED","sponsor":"University of Bristol","startDate":"2020-01-02","conditions":"Parkinson Disease","enrollment":600},{"nctId":"NCT06041789","phase":"PHASE2","title":"Effect of Acetylcholinesterase Inhibitors on Bone Metabolism","status":"RECRUITING","sponsor":"Duke University","startDate":"2025-02-03","conditions":"Osteoporosis","enrollment":45},{"nctId":"NCT07152418","phase":"","title":"Therapeutic Efficacy of Monoclonal Antibody Drugs for Alzheimer's Disease Based on PET Research","status":"NOT_YET_RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-09-01","conditions":"Alzheimer Disease (AD), Alzheimer Dementia, Mild Cognitive Impairment (MCI)","enrollment":120},{"nctId":"NCT05887375","phase":"PHASE4","title":"Sugammadex vs Neostigmine/Glycopyrrolate on Urinary Retention After Spine Surgery","status":"ENROLLING_BY_INVITATION","sponsor":"University of Missouri-Columbia","startDate":"2023-08-03","conditions":"Spine Surgery, Reversal of Neuromuscular Blockade, Urinary Retention Postoperative","enrollment":118},{"nctId":"NCT06871839","phase":"","title":"The Clinical Study of Synaptic Plasticity-based Lencanumab for the Treatment of Early Alzheimer's Disease","status":"RECRUITING","sponsor":"Cuibai Wei，Clinical Professor","startDate":"2025-03-10","conditions":"Alzheimer's Disease, Lecanemab, Functional Magnetic Resonance Imaging","enrollment":120},{"nctId":"NCT06518941","phase":"PHASE2","title":"An Open Trial of a Novel Pharmacotherapy for Habit Modification in Anorexia Nervosa","status":"NOT_YET_RECRUITING","sponsor":"New York State Psychiatric Institute","startDate":"2026-06","conditions":"Anorexia Nervosa","enrollment":10},{"nctId":"NCT06862960","phase":"PHASE2","title":"Ozanimod in Patients With Alzheimer's Disease","status":"NOT_YET_RECRUITING","sponsor":"ChenXiaoChun","startDate":"2025-07-01","conditions":"Alzheimer Disease","enrollment":40},{"nctId":"NCT02255799","phase":"PHASE3","title":"Multicenter Evaluation of Memory Remediation After TBI With Donepezil","status":"COMPLETED","sponsor":"Baylor College of Medicine","startDate":"2013-09-01","conditions":"Traumatic Brain Injury, Memory Deficits","enrollment":75},{"nctId":"NCT06687993","phase":"PHASE2","title":"Acetylcholinesterase Inhibitor in Anorexia Nervosa: Multicenter, Double-Blind, Placebo-Controlled Trial","status":"NOT_YET_RECRUITING","sponsor":"Centre Hospitalier St Anne","startDate":"2024-11","conditions":"Anorexia Nervosa Restricting Type","enrollment":147},{"nctId":"NCT06149013","phase":"NA","title":"Efficacy of MindAhead's Digital Behavioral Activation Therapy in Adults with MCI or Mild Dementia","status":"COMPLETED","sponsor":"MindAhead UG","startDate":"2023-12-21","conditions":"Mild Cognitive Impairment, Mild Dementia","enrollment":50},{"nctId":"NCT03101722","phase":"NA","title":"Effects of Huperzine a on Presbycusis(Δ,kHz, DB,MMSE, AD)","status":"ENROLLING_BY_INVITATION","sponsor":"Zhijun Bao","startDate":"2017-05-15","conditions":"Presbycusis, Tinnitus, Cognitive Impairment","enrollment":60},{"nctId":"NCT01442766","phase":"PHASE1, PHASE2","title":"Donepezil Trial for Motor Recovery in Acute Stroke","status":"WITHDRAWN","sponsor":"Imperial College London","startDate":"2011-11","conditions":"Acute Stroke","enrollment":""},{"nctId":"NCT05647473","phase":"PHASE2","title":"Efficacy, Safety and Response Predictors of Adjuvant Astragalus for Cognition in Orthostatic Hypotension","status":"UNKNOWN","sponsor":"Fujian Medical University Union Hospital","startDate":"2024-02-20","conditions":"Orthostatic Hypotension, Alzheimer Disease","enrollment":66},{"nctId":"NCT03840837","phase":"PHASE4","title":"Cholinergic Neurotransmission in Mobility and Cognition in Parkinson Disease","status":"COMPLETED","sponsor":"University of Maryland, Baltimore","startDate":"2019-05-02","conditions":"Parkinson Disease, Parkinson Disease Dementia","enrollment":31},{"nctId":"NCT02227823","phase":"PHASE2","title":"Safety and Efficacy Study of Pyridostigmine on Patients With Spinal Muscular Atrophy Type 3","status":"COMPLETED","sponsor":"Centre Hospitalier Régional de la Citadelle","startDate":"2014-07","conditions":"Spinal Muscular Atrophy Type 3","enrollment":4},{"nctId":"NCT04901494","phase":"","title":"SSRI's and the Rate of Progression From MCI to Dementia","status":"WITHDRAWN","sponsor":"Ohio State University","startDate":"2021-09-01","conditions":"Mild Cognitive Impairment, Dementia, Alzheimer Disease","enrollment":""},{"nctId":"NCT03454646","phase":"PHASE4","title":"Comparison of Therapeutic Strategies With Cholinesterase Inhibitors (SOS TRIAL)","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Bordeaux","startDate":"2024-06-01","conditions":"Alzheimer Disease, Cholinesterase Inhibitors","enrollment":1205},{"nctId":"NCT01872598","phase":"PHASE3","title":"Masitinib in Patients With Mild to Moderate Alzheimer's Disease","status":"COMPLETED","sponsor":"AB Science","startDate":"2012-01","conditions":"Alzheimer Disease","enrollment":721},{"nctId":"NCT04951726","phase":"PHASE4","title":"Neostigmine Route for Acute Colonic Pseudo Obstruction","status":"UNKNOWN","sponsor":"University of Southern California","startDate":"2022-02-04","conditions":"Ogilvie Syndrome","enrollment":90},{"nctId":"NCT01539031","phase":"PHASE3","title":"Compare the Efficacy and Safety of Donepezil Hydrochloride 23 mg Treatment With Continuation of Donepezil Hydrochloride 10 mg Treatment in Japanese Subjects With Severe Alzheimer's Disease","status":"COMPLETED","sponsor":"Eisai Co., Ltd.","startDate":"2012-03","conditions":"Alzheimer's Type Dementia","enrollment":351},{"nctId":"NCT04754152","phase":"NA","title":"Long-term Effect of θ Burst Magnetic Stimulation on Clinical Symptoms of Alzheimer Disease","status":"COMPLETED","sponsor":"Anhui Medical University","startDate":"2021-04-21","conditions":"Repetitive Transcranial Magnetic Stimulation","enrollment":45},{"nctId":"NCT05532644","phase":"","title":"Correlation of P-glycoprotein Polymorphisms With Microbial Metabolites in Patients With Alzheimer's Disease on Medication","status":"UNKNOWN","sponsor":"Aristotle University Of Thessaloniki","startDate":"2022-09","conditions":"Alzheimer Disease","enrollment":135},{"nctId":"NCT05102552","phase":"EARLY_PHASE1","title":"Evaluating the Safety and Relative Bioavailability of Three SPN-817 Treatments (A, B and C) in Healthy Adult Subjects","status":"COMPLETED","sponsor":"Supernus Pharmaceuticals, Inc.","startDate":"2021-10-19","conditions":"Healthy Volunteer","enrollment":30},{"nctId":"NCT03937908","phase":"EARLY_PHASE1","title":"Pharmacokinetics Centella Asiatica Product (CAP) in Mild Cognitive Impairment","status":"TERMINATED","sponsor":"Oregon Health and Science University","startDate":"2019-10-31","conditions":"Cognitive Impairment, Elderly","enrollment":5},{"nctId":"NCT01727193","phase":"PHASE3","title":"The Efficacy and Safety of Leflunomide or Azathioprine Therapy in Myasthenia Gravis Patients After Expand Thymectomy","status":"COMPLETED","sponsor":"First Affiliated Hospital, Sun Yat-Sen University","startDate":"2012-09","conditions":"Myasthenia Gravis","enrollment":290},{"nctId":"NCT05321680","phase":"NA","title":"Withdrawal of Antidementia Drugs in Advanced Dementia (WADAD)","status":"COMPLETED","sponsor":"Centro Hospitalar De São João, E.P.E.","startDate":"2021-03-01","conditions":"Dementia","enrollment":16},{"nctId":"NCT05102045","phase":"NA","title":"The Effects of Repetitive Transcranial Magnetic Stimulation in Patients With Alzheimer's Disease","status":"COMPLETED","sponsor":"Istanbul Medipol University Hospital","startDate":"2016-09-01","conditions":"Alzheimer Disease","enrollment":27},{"nctId":"NCT01521117","phase":"PHASE4","title":"The Effect of Donepezil on Gait and Balance in Parkinson's Disease","status":"COMPLETED","sponsor":"Oregon Health and Science University","startDate":"2011-12","conditions":"Parkinson's Disease","enrollment":21},{"nctId":"NCT03565809","phase":"","title":"Quality of the Management of Diabetes in Elderly People With Dementia in France","status":"COMPLETED","sponsor":"University Hospital, Toulouse","startDate":"2017-05-02","conditions":"Alzheimer Disease","enrollment":87816},{"nctId":"NCT03221894","phase":"","title":"A Retrospective Study to Investigate the Additive Effectiveness of Chinese Herbal Medicine in Alzheimer's Disease","status":"COMPLETED","sponsor":"Dongzhimen Hospital, Beijing","startDate":"2017-07-15","conditions":"Alzheimer Disease","enrollment":120},{"nctId":"NCT01690195","phase":"PHASE2","title":"Safety and Tolerability Study Evaluating a New Treatment for Subjects With Mild to Moderate Alzheimer's Disease","status":"TERMINATED","sponsor":"AbbVie (prior sponsor, Abbott)","startDate":"2012-09","conditions":"Alzheimer's Disease","enrollment":343},{"nctId":"NCT02220738","phase":"PHASE1","title":"Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ABT-957 in Subjects With Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors","status":"TERMINATED","sponsor":"AbbVie","startDate":"2014-09","conditions":"Alzheimer's Disease","enrollment":19},{"nctId":"NCT01584076","phase":"PHASE1","title":"Treatment of Residual Amblyopia With Donepezil","status":"COMPLETED","sponsor":"Boston Children's Hospital","startDate":"2012-08","conditions":"Amblyopia","enrollment":18},{"nctId":"NCT02080364","phase":"PHASE3","title":"Evaluation of the Efficacy and Safety of Azeliragon (TTP488) in Patients With Mild Alzheimer's Disease","status":"TERMINATED","sponsor":"vTv Therapeutics","startDate":"2015-04","conditions":"Alzheimer's Disease","enrollment":880},{"nctId":"NCT00151502","phase":"PHASE3","title":"To Evaluate the Safety and Effectiveness of Atorvastatin Plus a Cholinesterase Inhibitor in AD Patients.","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2002-11","conditions":"Alzheimer's Disease","enrollment":600},{"nctId":"NCT04423276","phase":"PHASE4","title":"Efficiency of Donepezil in Elderly Patients for Prevention of POCD Dysfunction","status":"UNKNOWN","sponsor":"RenJi Hospital","startDate":"2020-06-14","conditions":"Total Knee Arthroplasty, Fracture of Head of Femur Articular Displaced, Protrusion of Intervertebral Disc","enrollment":360},{"nctId":"NCT04647955","phase":"PHASE4","title":"Functional Dyspepsia: Validation of a Questionnaire for Symptom Assessment in FD PDS Subgroup","status":"COMPLETED","sponsor":"Universitaire Ziekenhuizen KU Leuven","startDate":"2013-02-22","conditions":"Functional Dyspepsia, Postprandial Fullness Syndrome","enrollment":100},{"nctId":"NCT04041349","phase":"PHASE4","title":"Clinical Observation for the Therapeutic Effect of mNGF on Cognitive Decline in Cerebral Small Vessel Disease","status":"UNKNOWN","sponsor":"Zhujiang Hospital","startDate":"2019-09-07","conditions":"Cerebral Small Vessel Diseases","enrollment":50},{"nctId":"NCT02248636","phase":"PHASE2, PHASE3","title":"Cholinesterase Inhibitor Discontinuation","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2015-01-22","conditions":"Dementia","enrollment":72},{"nctId":"NCT01951118","phase":"PHASE4","title":"Olfactory Deficits and Donepezil Treatment in Cognitively Impaired Elderly","status":"COMPLETED","sponsor":"New York State Psychiatric Institute","startDate":"2013-10","conditions":"Alzheimer Disease, Mild Cognitive Impairment, Delirium, Dementia, Amnestic, Cognitive Disorders","enrollment":121},{"nctId":"NCT00277810","phase":"PHASE2, PHASE3","title":"Study Evaluating the Safety, Tolerability, and Efficacy of Lecozotan SR in Outpatients With Alzheimer's Disease","status":"COMPLETED","sponsor":"Pfizer","startDate":"2006-03","conditions":"Alzheimer Disease","enrollment":250},{"nctId":"NCT04379440","phase":"","title":"Geriatric Population COVID-19 Observational Study (GEROCOVIDobs)","status":"UNKNOWN","sponsor":"Raffaele Antonelli Incalzi","startDate":"2020-04-25","conditions":"COVID-19","enrollment":1500},{"nctId":"NCT02773173","phase":"PHASE4","title":"Individualized Pneumoperitoneum Pressure in Colorectal Laparoscopic Surgery Versus Standard Therapy (IPPCollapse-II)","status":"COMPLETED","sponsor":"Instituto de Investigacion Sanitaria La Fe","startDate":"2017-01-25","conditions":"Colorectal Surgery, Laparoscopy","enrollment":204},{"nctId":"NCT03312244","phase":"PHASE2","title":"Pyridostigmine as Immunomodulator in People Living With HIV","status":"SUSPENDED","sponsor":"Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran","startDate":"2019-07-01","conditions":"HIV-1-infection, CD4+ T Lymphocytopenia, Immune Deficiency","enrollment":60},{"nctId":"NCT01880099","phase":"NA","title":"A Study to Help People Quit Smoking.","status":"COMPLETED","sponsor":"Yale University","startDate":"2013-12","conditions":"Nicotine Dependence","enrollment":60},{"nctId":"NCT02927522","phase":"PHASE3","title":"Donepezil Attenuate Postoperative Cognitive Dysfunction","status":"UNKNOWN","sponsor":"RenJi Hospital","startDate":"2018-09-01","conditions":"Osteoarthritis, Femoral Head Necrosis, Rheumatoid Arthritis","enrollment":550},{"nctId":"NCT03944473","phase":"PHASE4","title":"Efficacy and Safety of Sugammadex in High-Risk Ambulatory Surgeries","status":"WITHDRAWN","sponsor":"Montefiore Medical Center","startDate":"2019-06-20","conditions":"Ambulatory Difficulty","enrollment":""},{"nctId":"NCT01250977","phase":"PHASE2","title":"Effect of Donepezil on Smoking","status":"COMPLETED","sponsor":"Abramson Cancer Center at Penn Medicine","startDate":"2011-01-11","conditions":"Smoking","enrollment":30},{"nctId":"NCT03988179","phase":"","title":"Predicting Delirium by Attentional Dysfunction","status":"COMPLETED","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2014-04-04","conditions":"Delirium in Old Age","enrollment":172},{"nctId":"NCT00482001","phase":"PHASE4","title":"Impact of Cholinesterase Inhibitors on Driving Ability in Healthy Older Adults","status":"COMPLETED","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2007-06","conditions":"Mental Health, Geriatrics","enrollment":22},{"nctId":"NCT02258152","phase":"PHASE2","title":"SYN120 Study to Evaluate Its Safety, Tolerability and Efficacy in Parkinson's Disease Dementia (SYNAPSE)","status":"COMPLETED","sponsor":"Biotie Therapies Inc.","startDate":"2014-12-22","conditions":"Parkinson's Disease Dementia (PDD)","enrollment":82},{"nctId":"NCT01828294","phase":"PHASE1","title":"Subcutaneous Ig Maintenance Therapy for Myasthenia Gravis","status":"TERMINATED","sponsor":"St. Louis University","startDate":"2011-10","conditions":"Myasthenia Gravis","enrollment":4},{"nctId":"NCT03063515","phase":"PHASE1","title":"AchE Inhibitor and Insulin","status":"COMPLETED","sponsor":"University of Miami","startDate":"2017-04-19","conditions":"Diabetes Mellitus","enrollment":12},{"nctId":"NCT01669538","phase":"PHASE2","title":"Effect of Galantamine on Short-term Abstinence","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2012-08","conditions":"Tobacco Use Disorder","enrollment":98},{"nctId":"NCT02450786","phase":"PHASE2","title":"Effect of Donepezil on Cognition in Parkinson's Disease With Mild Cognitive Impairment (PD-MCI)","status":"UNKNOWN","sponsor":"Yonsei University","startDate":"2015-06","conditions":"Parkinson's Disease","enrollment":80},{"nctId":"NCT01856738","phase":"PHASE4","title":"Cholinesterase Inhibitors to Slow Progression of Visual Hallucinations in Parkinson&Apos;s Disease","status":"TERMINATED","sponsor":"Amsterdam UMC, location VUmc","startDate":"2013-11","conditions":"Parkinson's Disease","enrollment":91},{"nctId":"NCT00768261","phase":"PHASE4","title":"Corticolimbic Degeneration and Treatment of Dementia","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2004-11","conditions":"Dementia","enrollment":39},{"nctId":"NCT02623764","phase":"","title":"EEG-cholinergic Index and Clinical Response to Treatment With Cholinesterase Inhibitors","status":"UNKNOWN","sponsor":"Landspitali University Hospital","startDate":"2015-12","conditions":"Alzheimer´s Disease","enrollment":218},{"nctId":"NCT02007291","phase":"","title":"Good Rate of Clinical Response to Cholinesterase Inhibitors in Alzheimer's Disease After Three Months of Treatment","status":"COMPLETED","sponsor":"Federal University of Minas Gerais","startDate":"2009-06","conditions":"Late Onset Alzheimer","enrollment":71},{"nctId":"NCT00940589","phase":"PHASE2","title":"Efficacy of Circadin® 2 mg in Patients With Mild to Moderate Alzheimer Disease Treated With AChE Inhibitor","status":"COMPLETED","sponsor":"Neurim Pharmaceuticals Ltd.","startDate":"2009-09","conditions":"Alzheimer's Disease, Sleep Disorder","enrollment":73},{"nctId":"NCT03445104","phase":"EARLY_PHASE1","title":"Effect of Huperzine A on Cognitive Function and Perception of Effort During Exercise","status":"COMPLETED","sponsor":"St. Louis University","startDate":"2018-01-16","conditions":"Cognitive Enhancement During Exercise","enrollment":15},{"nctId":"NCT02357225","phase":"EARLY_PHASE1","title":"A Pilot Study of Pyridostigmine in Pompe Disease","status":"TERMINATED","sponsor":"University of Florida","startDate":"2015-08","conditions":"Pompe Disease","enrollment":2},{"nctId":"NCT03505255","phase":"PHASE4","title":"Comparison Between Intraperitoneal Versus Intramuscular Neostigmine on Pattern of Postoperative GIT Motility in Patients Undergoing Laparoscopic Cholecystectomy","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2018-09-01","conditions":"Pattern of GIT Motility","enrollment":160},{"nctId":"NCT03011476","phase":"PHASE4","title":"Effect of Acetylcholinesterase Inhibitors on the Gait of the Patients With Parkinson Disease","status":"UNKNOWN","sponsor":"Kyung Hee University Hospital","startDate":"2017-04-11","conditions":"Parkinson Disease","enrollment":20},{"nctId":"NCT01670526","phase":"PHASE3","title":"Rivastigmine Patch in Veterans With Cognitive Impairment Following TBI","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2012-12","conditions":"Traumatic Brain Injury, Cognitive Impairment","enrollment":94},{"nctId":"NCT02006654","phase":"PHASE3","title":"Study of Idalopirdine in Patients With Mild - Moderate Alzheimer's Disease Treated With an Acetylcholinesterase Inhibitor","status":"COMPLETED","sponsor":"H. Lundbeck A/S","startDate":"2014-03","conditions":"Alzheimer's Disease","enrollment":734},{"nctId":"NCT01548638","phase":"PHASE2","title":"Effect of Galantamine on Smoking Abstinence","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2012-02","conditions":"Nicotine Addiction","enrollment":13},{"nctId":"NCT00227994","phase":"PHASE4","title":"Acetylcholinesterase Inhibitors to Improve Cognitive Function and Overall Rehabilitation After a Stroke","status":"COMPLETED","sponsor":"University of Pittsburgh","startDate":"2003-04","conditions":"Cerebrovascular Accident","enrollment":40},{"nctId":"NCT01014858","phase":"PHASE3","title":"Multi-centre UK Study of the Acetylcholinesterase Inhibitor Donepezil in Early Dementia Associated With Parkinson's Disease","status":"TERMINATED","sponsor":"Newcastle-upon-Tyne Hospitals NHS Trust","startDate":"2013-01","conditions":"Parkinson's Disease","enrollment":64},{"nctId":"NCT00348140","phase":"PHASE3","title":"Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy In Subjects With Mild To Moderate Alzheimer's Disease","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2006-07-12","conditions":"Alzheimer's Disease","enrollment":1468},{"nctId":"NCT01415921","phase":"PHASE2","title":"Safety Study of Pyridostigmine in Heart Failure","status":"COMPLETED","sponsor":"NYU Langone Health","startDate":"2011-10","conditions":"Heart Failure","enrollment":33},{"nctId":"NCT02305836","phase":"PHASE2","title":"Effect of Electroacupuncture Combined With Donepezil for Treating Alzheimer's Disease","status":"UNKNOWN","sponsor":"Guang'anmen Hospital of China Academy of Chinese Medical Sciences","startDate":"2017-06","conditions":"Cognitive Impairment","enrollment":334},{"nctId":"NCT02035982","phase":"PHASE3","title":"Discontinuation of Cholinesterase Inhibitors for the Treatment of Severe Alzheimer's Disease","status":"COMPLETED","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2010-07","conditions":"Alzheimer's Disease, Dementia","enrollment":40},{"nctId":"NCT01519271","phase":"PHASE4","title":"Mild Cognitive Impairment in Parkinson's Disease","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2011-12","conditions":"Parkinson's Disease, Mild Cognitive Impairment","enrollment":28},{"nctId":"NCT01404169","phase":"PHASE3","title":"A 24-weeks, Multi-center, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Donepezil Hydrochloride in Chinese Subjects With Severe Alzheimer's Disease","status":"COMPLETED","sponsor":"Eisai Limited","startDate":"2011-09","conditions":"Alzheimer's Type Dementia","enrollment":260},{"nctId":"NCT03038035","phase":"PHASE2","title":"The Alzheimer's Disease THErapy With NEuroaid (ATHENE) Study","status":"UNKNOWN","sponsor":"National University Hospital, Singapore","startDate":"2016-12","conditions":"Alzheimer Disease","enrollment":150},{"nctId":"NCT01529619","phase":"PHASE4","title":"Efficacy, Safety and Tolerability of Rivastigmine Patch in Patients With Mild to Moderate Alzheimer's Disease Switched From Cholinesterase Inhibitors","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2012-03","conditions":"Alzheimer's Disease","enrollment":52},{"nctId":"NCT02860338","phase":"","title":"COMPARATIVE EFFECTIVENESS OF MCI and DEMENTIA TREATMENTS IN A COMMUNITY-BASED DEMENTIA PRACTICE","status":"COMPLETED","sponsor":"Clionsky Neuro Systems Inc.","startDate":"2009-01","conditions":"Mild Cognitive Impairment, Dementia, Hypoxia","enrollment":900},{"nctId":"NCT01487317","phase":"PHASE3","title":"Rivastigmine in the Management of Delirium","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2011-06","conditions":"Delirium","enrollment":23},{"nctId":"NCT01969123","phase":"PHASE3","title":"Study of the Safety and Effectiveness of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease","status":"TERMINATED","sponsor":"FORUM Pharmaceuticals Inc","startDate":"2013-10","conditions":"Alzheimer's Disease, Dementia","enrollment":474},{"nctId":"NCT02004392","phase":"PHASE3","title":"Study of the Safety and Clinical Effects of 2 Doses of EVP-6124 in Subjects With Alzheimer's Disease Who Complete Study EVP-6124-024 or EVP-6124-025","status":"TERMINATED","sponsor":"FORUM Pharmaceuticals Inc","startDate":"2014-06","conditions":"Alzheimer's Disease, Dementia","enrollment":348},{"nctId":"NCT01969136","phase":"PHASE3","title":"Study of the Safety and Effectiveness of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease","status":"TERMINATED","sponsor":"FORUM Pharmaceuticals Inc","startDate":"2013-10","conditions":"Alzheimer's Disease, Dementia","enrollment":403},{"nctId":"NCT01944436","phase":"","title":"A Genetic and Perfusion Study of Response to Cognitive Enhancers in Lewy Body Disease","status":"COMPLETED","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2006-09","conditions":"Lewy Body Disease","enrollment":57},{"nctId":"NCT00594633","phase":"PHASE1","title":"Adjunctive Donepezil Therapy and Genetic Risk Factors of Cognitive Dysfunction in Brain Tumor Survivors","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2004-10","conditions":"Brain Tumor, Brain Cancer, Cns Cancer","enrollment":25},{"nctId":"NCT02305589","phase":"","title":"The Clinical Changes Before and After Sugammadex in the Patients Undergoing Hip Surgery on the Aspect of Delirium","status":"UNKNOWN","sponsor":"Konkuk University Medical Center","startDate":"2014-09","conditions":"Delirium","enrollment":250},{"nctId":"NCT02403063","phase":"PHASE4","title":"Electromyographic Activity of the Respiratory Muscles During Neostigmine or Sugammadex Enhanced Recovery After Neuromuscular Blockade","status":"COMPLETED","sponsor":"Onze Lieve Vrouw Hospital","startDate":"2015-09","conditions":"Respiratory Muscles, Electromyography","enrollment":18},{"nctId":"NCT02246075","phase":"PHASE2","title":"Study of the Safety of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease Currently Receiving Memantine","status":"WITHDRAWN","sponsor":"FORUM Pharmaceuticals Inc","startDate":"2015-07","conditions":"Alzheimer's Disease, Dementia, Cognition","enrollment":""},{"nctId":"NCT01171118","phase":"NA","title":"Phamacological Reversal of Airway Instability During Sedation","status":"COMPLETED","sponsor":"University of Rochester","startDate":"2009-08","conditions":"Upper Airway Obstruction","enrollment":10},{"nctId":"NCT02413554","phase":"PHASE4","title":"Rivastigmine Patch Effect on the Post-operative Delirium in Patients at Risk of Dementia.","status":"COMPLETED","sponsor":"Chung-Ang University Hosptial, Chung-Ang University College of Medicine","startDate":"2013-04","conditions":"Delirium","enrollment":62},{"nctId":"NCT00423228","phase":"NA","title":"Efficacy Study of a ZT-1 Implant in Patients Suffering From Alzheimer's Disease","status":"COMPLETED","sponsor":"Debiopharm International SA","startDate":"2007-02","conditions":"Moderate Alzheimer's Disease","enrollment":228},{"nctId":"NCT01549834","phase":"PHASE2","title":"Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors","status":"COMPLETED","sponsor":"AbbVie (prior sponsor, Abbott)","startDate":"2012-03","conditions":"Alzheimer's Disease","enrollment":434},{"nctId":"NCT02187276","phase":"","title":"The Predictive Factors of Good Clinical Response to Cholinesterase Inhibitors in Alzheimer Disease and Mixed Dementia","status":"COMPLETED","sponsor":"Federal University of Minas Gerais","startDate":"2009-06","conditions":"Alzheimer Disease, Late Onset","enrollment":129},{"nctId":"NCT01276353","phase":"PHASE2","title":"A Study Versus E2020 10mg Followed by an Open-label Extension Phase to Explore the Safety of E2020 SR 23 mg in Japanese Subjects With Severe Alzheimer's Type Dementia","status":"COMPLETED","sponsor":"Eisai Inc.","startDate":"2011-01","conditions":"Alzheimer's Type Dementia","enrollment":45},{"nctId":"NCT01626391","phase":"PHASE2","title":"Safety Study of TRx0237 in Patients Already Taking Medications for Mild and Moderate Alzheimer's Disease","status":"TERMINATED","sponsor":"TauRx Therapeutics Ltd","startDate":"2012-09","conditions":"Alzheimer's Disease","enrollment":9},{"nctId":"NCT01009476","phase":"","title":"Long-term Use of Galantamine Versus Nootropics (Memory Enhancing Drugs) in Patients With Alzheimer's Dementia Under Conditions of Daily Routine","status":"COMPLETED","sponsor":"Janssen-Cilag G.m.b.H","startDate":"2006-03","conditions":"Dementia, Alzheimer Disease, Dementia, Vascular","enrollment":1134}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2464,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Galantamine, Donepezil, Rivastigmine"],"phase":"phase_3","status":"active","brandName":"Cholinesterase Inhibitor","genericName":"Cholinesterase Inhibitor","companyName":"Sunnybrook Health Sciences Centre","companyId":"sunnybrook-health-sciences-centre","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Cholinesterase inhibitors block the enzyme that breaks down acetylcholine, allowing acetylcholine to accumulate in the synapse and enhance cholinergic neurotransmission. Used for Alzheimer's disease (cognitive decline), Myasthenia gravis.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}